Markt für Produkte für trockene Augen – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPRE00012323
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 217
Buy Now

Die Größe des Marktes für Produkte für trockene Augen wird voraussichtlich von 6,95 Milliarden US-Dollar im Jahr 2023 auf 6,95 Milliarden US-Dollar wachsen 10,04 Milliardenbis 2031, was einer durchschnittlichen jährlichen Wachstumsrate von 4,7 % im Zeitraum 2023–2031 entspricht.

Der Bericht enthält Wachstumsaussichten aufgrund der aktuellen Markttrends für Produkte für trockene Augen und ihrer vorhersehbaren Auswirkungen im Prognosezeitraum. Trockenes Auge ist eine Erkrankung, die dadurch gekennzeichnet ist, dass die Tränenflüssigkeit nicht ausreichend ist, um das Auge zu befeuchten und zu nähren, oder dass die Tränenflüssigkeit schnell verdunstet. Durch hormonelle Veränderungen nimmt mit zunehmendem Alter die Neigung zur Tränenproduktion ab. Trockene Augen treten sowohl bei Männern als auch bei Frauen häufig auf. Allerdings werden mehr Fälle bei Frauen registriert, vor allem bei Frauen, die sich in den Wechseljahren befinden. Trockenes Auge ist eine chronische Erkrankung, für die es keine spezifische Heilung gibt, aber Behandlungen können helfen, die Symptome zu lindern. Es wird erwartet, dass Entwicklungsländer in den kommenden Jahren erhebliche Wachstumschancen für den Markt für Produkte für trockene Augen bieten werden.

Wachstumstreiber:

Anstieg der geriatrischen Bevölkerung treibt Marktwachstum für Produkte für trockene Augen

voran

Das Syndrom des trockenen Auges ist eine häufige Augenerkrankung, von der ein erheblicher Teil der Bevölkerung betroffen ist, insbesondere Menschen über 50. Erwachsene im mittleren und höheren Alter sind häufiger von diesem Syndrom betroffen, das damit in Verbindung gebracht werden kann mit der Verwendung von Kontaktlinsen, der Prävalenz von Autoimmunerkrankungen, systemischen Arzneimittelwirkungen und refraktiven Operationen. Die Belastung durch das Syndrom des trockenen Auges würde aufgrund der steigenden Lebenserwartung und der steigenden Fälle unter der älteren Bevölkerung weiter ansteigen. Nach Angaben der Weltgesundheitsorganisation (WHO) würde die Bevölkerung im Alter von 60 Jahren und älter von 1 Milliarde im Jahr 2020 auf 1,4 Milliarden im Jahr 2030 ansteigen; Die Zahl dürfte sich bis 2050 weiter verdoppeln und etwa 2 Milliarden erreichen. Die Zahl der Menschen im Alter von 80 Jahren und älter wird sich von 2020 bis 2050 voraussichtlich verdreifachen und 426 Millionen erreichen. Laut einem von der American Academy of Ophthalmology veröffentlichten Artikel steigt das Risiko einer KCS mit zunehmendem Alter. Die Prävalenz des Trockenen Auges reicht von 2,7 % bei Personen im Alter von 18 bis 34 Jahren bis zu 18,6 % bei Personen ab 75 Jahren. Die Centers for Disease Control and Prevention (CDC) geben an, dass in den USA die Prävalenz der diabetischen Retinopathie bei Menschen unter 25 Jahren am niedrigsten (13,0 %) und bei Menschen in der Altersgruppe von 65 bis 79 Jahren am höchsten war (28,4 %). Daher steigt die Nachfrage nach Produkten für trockene Augen wie künstlichen Tränen mit der wachsenden geriatrischen Bevölkerung weltweit.

Strategische Einblicke

Berichtssegmentierung und -umfang:

Die < Die span>Marktanalyse für Produkte für trockene Augen erfolgt unter Berücksichtigung der folgenden Segmente: Produkt, Dosierungsform, Typ und Vertriebskanal.

Segmentanalyse:

Nach Produkt ist der Markt für Produkte für trockene Augen kann Stakeholdern auf diesem Markt dabei helfen, ihre Wachstumsstrategien zu planen. Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA und Alcon AG gehören zu den führenden Unternehmen im Bereich Produkte für trockene Augen Marktbericht. Diese Unternehmen konzentrieren sich auf die Entwicklung neuer Technologien, die Modernisierung bestehender Produkte und den Ausbau ihrer geografischen Präsenz, um der wachsenden Verbrauchernachfrage weltweit gerecht zu werden. Laut Pressemitteilungen des Unternehmens sind im Folgenden einige aktuelle Entwicklungen großer Unternehmen auf dem Markt aufgeführt:

    •Im September 2023 wurde Bausch + Lomb Corporation (Bausch + Lomb), eine Tochtergesellschaft von Bausch Health Companies Inc, hat die Übernahme von XIIDRA (Lifitegrast-Augenlösung) 5 % abgeschlossen, einem nichtsteroidalen Augentropfen, der speziell zur Behandlung der Anzeichen und Symptome des trockenen Auges zugelassen ist. Das Produkt konzentriert sich speziell auf Entzündungen im Zusammenhang mit trockenen Augen und bestimmten anderen ophthalmologischen Wirkstoffen.•Im November 2022 brachte Santen Pharmaceutical Co Ltd in Japan DIQUAS LX Ophthalmic Solution 3 % (Diquafosol-Natrium) auf den Markt. Bei der DIQUAS LX-Lösung handelt es sich um eine Formulierung, die die Verabreichung von dreimal täglich einem Tropfen zur Behandlung des trockenen Auges erfordert.•Im August 2022 schlossen Alcon und Aerie Pharmaceuticals Inc. eine endgültige Fusionsvereinbarung. Im Rahmen dieser Transaktion erwarb Alcon Aerie. Diese Transaktion trägt dazu bei, die Präsenz von Alcon im Bereich der Augenpharmazeutika mit seinem wachsenden Portfolio an kommerziellen Produkten und seiner Entwicklungspipeline zu stärken.•Im Juli 2021 wurde TheraTears von Prestige Consumer Healthcare übernommen Inc. Die Übernahme von TheraTears erweiterte das führende Augenpflege-Portfolio von Prestige und verschaffte dem Unternehmen neue langfristige Wachstumsaussichten.•Im Februar 2021 brachte Allergan Refresh Digital auf den Markt, einen neuen Gleitmittel-Augentropfen, der speziell für die Augenpflege entwickelt wurde Lindert Trockenheit und Irritationen, die durch längere Bildschirmnutzung verursacht werden.•Im Juni 2020 schlossen OCuSOFT Inc. und EKKDA Research LLC eine Vertriebsvereinbarung. Diese Partnerschaft hilft den Partnern, sich im Ophthalmologie- und Optometrie-Geschäft zu etablieren und weiterzuentwickeln. Die Projekte von EKKDA’s Research LLC konzentrieren sich im Wesentlichen auf die Augenpflege.•Im Mai 2020 erwarb AbbVie Inc Allergan plc als Teil der anorganischen Geschäftsstrategie des Unternehmens. Durch die Übernahme hat das Unternehmen Zugang zu den mit der Augenheilkunde verbundenen Märkten erhalten und sein Geschäftsportfolio erweitert.•Im Januar 2020 errichtete Santen Pharmaceutical Co Ltd im Rahmen seiner Geschäftsausweitung in China sein zweites Werk für seine chinesische Tochtergesellschaft „Santen Pharmaceutical (China) Co Ltd.“ um die wachsende Nachfrage nach Produkten in China zu unterstützen.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which distribution channel segment is dominating the dry eye products market?

The dry eye products market by distribution channel, is categorized into retail pharmacies, hospital pharmacies, and online pharmacies. The retail pharmacies segment held the largest dry eye products market share in 2023. The online pharmacies segment is anticipated to register the highest CAGR of 5.7%.

Which region is the fastest growing the dry eye products market?

Asia Pacific is expected to be the fastest growing region in the dry eye products market. The dry eye products market in Asia Pacific is expected to register the highest CAGR during the forecast period. According to NIH, in China, ~20–30% of people are diagnosed with dry eye conditions every year. The dry eye products market in China is quite competitive, with the presence of both domestic and international pharmaceutical companies. Novaliq has established a strategic cooperation with Jiangsu Hengrui Pharmaceuticals to manufacture, develop, and commercialize NOV03 for the treatment of dry eye disease.

Which product segment is dominating the dry eye products market?

The dry eye products market, based on product, is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest dry eye products market share in 2023. The anti-inflammatory drugs segment is anticipated to register the highest CAGR during 2023–2031.

Which dosage form segment is dominating the dry eye products market?

The dry eye products market by dosage form is bifurcated into OTC and prescription. The OTC segment held a larger share of the market in 2023, and it is anticipated to register a higher CAGR of 5.1% during 2023–2031.

What are the driving factors for the dry eye products market across the globe?

The factors that are driving growth of the market are the rising prevalence of dry eye and upsurge in geriatric population.

What are dry eye products?

Dry eye is a condition characterized by the lack of adequate quality of tears to lubricate and nourish the eye or by a quick evaporation of tears. With hormonal changes, as people get older, the tendency to produce tears decreases. Dry eye is common in both males and females. However, more cases are recorded in women, mainly those who have gone through menopause. Dry eye is a chronic condition that doesn’t have a specific cure, but treatments can help manage the symptoms.

Who are the major players in the dry eye products market?

The dry eye products market majorly consists of the players such as Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA and Alcon AG.

Which country is dominated the dry eye products market?

US holds the largest market share in dry eye products market. DED is a common but underdiagnosed condition in the US, and an increase in the population age can be associated with the surging prevalence of this disease. According to the Centers for Disease Control and Prevention (CDC), age-related eye diseases such as cataract, macular degeneration, diabetic retinopathy, and glaucoma are the primary causes of blindness and impaired vision in the US. Other common eye disorders include amblyopia and strabismus. Dry eye disease is expected to affect as many as 2.79 million US men by 2030.

The List of Companies - Dry Eye Products Market

  1. Santen Pharmaceutical Co., Ltd.
  2. Johnson & Johnson
  3. OASIS Medical
  4. URSAPHARM Arzneimittel GmbH
  5. Rohto Pharmaceutical Co Ltd
  6. OCuSOFT Inc.
  7. Bausch Health Companies Inc
  8. AbbVie Inc
  9. Prestige Consumer Healthcare Inc.
  10. Farmigea SpA
  11. Alcon AG

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports